Cellectar Biosciences, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $10.0M | $11.4M | $3.9M | $9.4M | $2.4M | $4.7M | $5.5M | $673.7K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $10.5M | $12.2M | $4.2M | $9.7M | $2.8M | $5.1M | $5.8M | $1.3M |
| Property, Plant & Equipment | $244.7K | $1.4M | $1.7M | $2.0M | $2.4M | $2.6M | $3.0M | $3.5M |
| Goodwill | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $12.9M | $15.3M | $7.6M | $13.4M | $6.8M | $11.5M | $10.6M | $4.8M |
| Liabilities | ||||||||
| Accounts Payable | $933.0K | — | — | — | — | — | — | — |
| Total Current Liabilities | $2.1M | $1.6M | $5.7M | $6.2M | $4.5M | $732.7K | $503.6K | $904.8K |
| Long-Term Debt | — | — | $330.2K | $450.0K | $450.0K | $450.0K | — | — |
| Total Liabilities | $2.1M | $1.8M | $5.9M | $6.7M | $5.1M | $1.3M | $1.1M | $4.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-84.3M | $-70.8M | $-64.6M | $-59.1M | $-51.1M | — | — | — |
| Total Stockholders' Equity | $10.8M | $13.5M | $1.6M | $6.7M | $1.7M | $10.2M | $9.5M | $133.8K |